COEP · Categories · Form 4
COEP - SEC Form 4 insider transactions
Coeptis Therapeutics Holdings Inc. (COEP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for COEP
- SEC Form 4 filed by Director Sohn Adam Craig4 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Chief Marketing Officer Schadel Christopher Ryan4 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Fuerst Bryan Eric4 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Co-Chief Executive Officer Halabu David Elias4 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Cooper Kenneth Lyle4 - Z Squared Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Cogley Brian4 - Z Squared Inc. (0001759186) (Issuer)
- Co-Chief Executive Officer Burke Michelle Ellen was granted 16,447 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- Director Deschamps Philippe exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- Chief Financial Officer Cogley Brian exercised 10,000 shares at a strike of $10.56 and was granted 12,500 shares, increasing direct ownership by 80% to 22,500 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- Director Cochran Christopher P. exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- Director Salkind Gene exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- Director Calise Chris exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- VP Operations Yerace Daniel Alexander was granted 20,000 shares and exercised 10,000 shares at a strike of $10.41, increasing direct ownership by 17% to 70,531 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- CEO and President Mehalick David exercised 148,875 shares at a strike of $7.05 and was granted 51,250 shares, increasing direct ownership by 82% to 330,192 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- VP Compliance and Secy Sheehy Christine Elise exercised 1,000 shares at a strike of $10.56 and was granted 12,500 shares, increasing direct ownership by 2% to 64,031 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- Director Desilva Tara was granted 3,250 shares and exercised 5,700 shares at a strike of $10.56, increasing direct ownership by 175% to 8,950 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Deschamps Philippe4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Cogley Brian4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by VP of Operations Yerace Daniel Alexander4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by VP Compliance and Secy Sheehy Christine Elise4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Salkind Gene4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by CEO and President Mehalick David4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Desilva Tara4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Cochran Christopher P.4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- SEC Form 4 filed by Director Calise Chris4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)